See
Genome Information for Mus musculus
Tumor dormancy, a resistance mechanism employed by cancer cells, poses a significant challenge in cancer treatment, contributing to minimal residual disease (MRD) and potential relapse.
More...Tumor dormancy, a resistance mechanism employed by cancer cells, poses a significant challenge in cancer treatment, contributing to minimal residual disease (MRD) and potential relapse. Despite its clinical importance, mechanisms underlying tumor dormancy and MRD remain unclear. In this study, we employed two syngeneic murine models of myeloid leukemia and melanoma to investigate the genetic, epigenetic, transcriptomic and protein signatures associated with tumor dormancy. We used a multi-omics approach to elucidate the molecular mechanisms driving MDR and identify potential therapeutic targets.
Less...| Accession | PRJNA1103364 |
| Data Type | Genome sequencing |
| Scope | Monoisolate |
| Organism | Mus musculus[Taxonomy ID: 10090] Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus; Mus musculus |
| Submission | Registration date: 23-Apr-2024
Lille University |
| Relevance | Medical |
| Locus Tag Prefix | AAG131 |
Project Data:
| Resource Name | Number
of Links |
|---|
| BioSample | 16 |
No public data is linked to this project. Any recently released data that cites this project will be linked to it within a few days.